Cost Plus Drugs co-founder Mark Cuban and Humana CEO Jim Rechtin hinted at their companies are working together, Forbes reported Dec. 4. “We’re talking to CenterWell,” Mr. Cuban said during the Forbes Healthcare Summit. “I would say we are treating…

Becker’s asked pharmacy leaders across the U.S. one question: What innovation are you looking to scale for 2026 — and why? Their answers reveal a sector doubling down on automation, access and operational resilience. Access at the point of care…

The CDC’s Advisory Committee on Immunization Practices voted 8-3 in favor of limiting national recommendations on which infants should receive a hepatitis B vaccine at birth.  The panel voted Dec. 5 to exclusively recommend the first hepatitis B shot to…

Pharmacists are carving out roles beyond the pharmacy counter, and Sterling Elliott, PharmD, clinical pharmacist lead for ambulatory surgery at Chicago-based Northwestern Medicine, says the shift is “essential for the future of U.S. healthcare.” Speaking on the “Becker’s Pharmacy Leadership…

Mark Cuban Cost Plus Drugs has expanded its partnership with GraphiteRx to support the Cost Plus Marketplace for Businesses. The platform combines Cost Plus Drugs’ pricing model with GraphiteRx’s marketplace technology to help hospitals, pharmacies and clinics access essential medications…

Tracy Beth Høeg, MD, PhD, was named acting director of the FDA’s Center for Drug Evaluation and Research, effective Dec. 3. Dr. Høeg previously served as senior adviser for clinical sciences in the agency’s Office of the Commissioner and the…

The Anesthesia Patient Safety Foundation and the Institute for Safe Medication Practices issued a joint warning urging hospitals to eliminate vials and ampules of tranexamic acid from perioperative settings due to the risk of fatal wrong-drug, wrong-route errors, according to…

Pharmacists with specialized training can now prescribe buprenorphine to treat opioid use disorder under a federal bill signed into law Dec. 1. The provision is part of the SUPPORT for Patients and Communities Reauthorization Act of 2025, and allows the…

CVS Pharmacy will pay $37.76 million to resolve allegations that it over-dispensed insulin pens and improperly billed federal health programs over a 10-year period. The settlement resolves claims that CVS pharmacies from 2010 to 2020 repeatedly refilled insulin prescriptions too…

For some hospitals and systems, pharmacy is the No. 1 revenue generator, but pharmacy department leaders say they’re often underutilized.  Darren Evans, PharmD, system vice president of pharmacy services and hospital operations at Albany, Ga.-based Phoebe Putney Health System, told…